KEY ASPECTS OF OUR GLP STUDY SERVICES
Compliance with GLP Standards
We ensure that all aspects of our GLP studies adhere to international Good Laboratory Practices, including proper study planning, execution, monitoring, recording, archiving, and reporting.
Study Design and Protocol Development
Our experts assist in designing studies and developing detailed protocols that meet specific research objectives while ensuring full GLP compliance. This includes identifying appropriate study models, controls, and methods – particularly when animal trials are required.
Quality Control and Assurance
We implement rigorous quality control and assurance procedures throughout each study, including oversight of documentation, data handling, and traceability – ensuring full integrity of results.
Data Management and Reporting
Our services include complete data management—from raw data collection to final reporting. We ensure that all reports are compliant with GLP and suitable for regulatory submission in both EU and international contexts.
Facility and Equipment Management
We maintain high standards for laboratory infrastructure, including equipment calibration and environmental control, to meet GLP conditions for pre-clinical testing.
Staff Training and Expertise
Our team comprises highly trained professionals with extensive knowledge of Good Laboratory Practices. Continuous training ensures that all study personnel are up to date with the latest GLP requirements and best practices.
WHY CHOOSE MDS FINLAND FOR GLP STUDIES?
Expertise in Pre-Clinical Research
We have extensive experience supporting GLP-compliant animal trials and laboratory studies for medical devices and combination products.
Regulatory Alignment
Our studies are structured to meet EU and international submission requirements, whether for CE marking or FDA approvals—ensuring your pre-clinical data stands up to global regulatory scrutiny.
Customizable Study Services
We tailor each GLP study to match your research objectives, timelines, and regulatory targets, whether for initial biocompatibility screening or full pre-market data generation.
ENSURING RELIABLE AND COMPLIANT PRE-CLINICAL STUDIES
MDS Finland’s Good Laboratory Practice services are vital for generating reliable, high-quality data in support of regulatory applications. Whether you require in vitro studies or animal trials, our GLP-compliant approach ensures that your data is accepted by regulatory authorities and supports safe and effective product development.